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A novel pore blockage-based electrochemical immunosensor based on the combination
of 100 nm-magnetic nanoparticles (MNPs), as signal enhancers, and 200 nm-pore
diameter nanoporous anodic alumina (NAA) membranes, as sensing platform, is
reported. A peptide conjugate mimicking flightless I (Flii), a wound healing biomarker,
was chosen as target analyte. The sensing platform consists of an anti-Flii antibody
(Ab1)-modified NAA membrane attached onto a gold electrode. Anti-KLH antibody
(Ab2)-modified MNPs (MNP-Ab2) were used to selectively capture the Flii peptide
conjugate in solution. Sensing was based on pore blockage of the Ab1-modified NAA
membrane caused upon specific binding of the MNP-Ab2-analyte complex. The degree
of pore blockage, and thus the concentration of the Flii peptide conjugate in the sample,
was measured as a reduction in the oxidation current of a redox species ([Fe(CN)6]
4−)
added in solution. We demonstrated that pore blockage is drastically enhanced by
applying an external magnetic field at the membrane backside to facilitate access of
the MNP-Ab2-analyte complex into the pores, and thus ensure its availability to bind to
the Ab1-modified NAAmembrane. Combining the pore blockage-based electrochemical
magnetoimmunosensor with an externally applied magnetic field, a limit of detection
(LOD) of 0.5 ng/ml of Flii peptide conjugate was achieved, while sensing in the absence
of magnetic field could only attain a LOD of 1.2µg/ml. The developed sensing strategy is
envisaged as a powerful solution for the ultra-sensitive detection of an analyte of interest
present in a complex matrix.
Keywords: magnetic nanoparticles, porous anodic aluminamembrane, pore blockage, electrochemical biosensor,
chronic wound, nanoporous materials
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INTRODUCTION
There is a growing demand for rapid, highly sensitive,
simple-to-fabricate, and cost-effective biosensing platforms for
the detection of biological targets in medical diagnostics.
Conventional methods like enzyme-linked immunosorbent
assays (ELISAs) are not desirable as diagnostic platforms in
clinical setups as they require long analysis time, sample
preparation and several incubation and rinsing steps prior
to analysis.
Electrochemical biosensors translate the presence of analytes
into electrical signals (Grieshaber et al., 2008) and are suitable
to develop point-of-care (POC) handheld sensing devices since
electrodes can be easily miniaturized by methods such as screen
printing (Yamanaka et al., 2016), photolithography (Mir et al.,
2010) or ink-jet printing (Silveira et al., 2016) which allow easy
integration into electronic devices (Zhu et al., 2014).
With substantial advancements in nanotechnology,
remarkable improvement in the sensing performance of
electrochemical biosensors has been achieved using nanoparticle
(NP)-based signal amplification (Zhu et al., 2014). Nowadays,
different kinds of functional nanomaterials such as metal
NPs, quantum dots, nanoporous materials, carbon-based
nanomaterials, and magnetic NPs (MNPs) have been used to
design ultra-sensitive biosensing platforms (Lei and Ju, 2012;
Walcarius et al., 2013; Holzinger et al., 2014).
MNPs have been extensively used in magnetic separation
of biomolecules from complex biological samples and as solid
supports for performing immunoassays (Rocha-Santos, 2014).
Advances in biosensing strategies that employ magnetic labels
have resulted in platforms that push the limits of detection to
very low levels resulting in devices that can be used for early
disease detection in medical diagnostics (Dittmer et al., 2008).
Nowadays, a variety of commercial MNPs are readily available
with a wide range of sizes, magnetic properties, and surface
functionalities that are used in biosensors. They have been used
for capturing analytes from complex samples, leaving behind
undesired molecules in the background matrix, and labeling
analytes (Van Reenen et al., 2014).
The main advantages of using MNPs include their large
surface area, ease of functionalization, lack of harmful effects
to the human body, controllable size, and simple manipulation
in magnetically actuated devices. Surface functionalities on
MNPs allow their surface modification with biorecognition
elements that feature high affinity to the analyte of interest,
whereas the large surface-to-volume ratio increases the
number of bioreceptors available to react with the analyte,
contributing to increase the sensitivity of the device (Dittmer
et al., 2008; Gijs et al., 2009; Peyman et al., 2009). The latter
effect can be further enhanced by the feasibility of MNPs
to facilitate pre-concentration of analytes prior to analysis,
being key for applications that require ultra-sensitivity
to detect minute concentrations of analyte. Additionally,
biofunctionalized MNPs can isolate specific analytes of interest
from complex biological samples by magnetic actuation, which
can minimize matrix effects thereby reducing the occurrence of
false positives.
Lab-on-chip technologies that integrate multiple analytical
functions in a single chip are of great interest to scientists
due to the growing demand for easy-to-use diagnostic devices
(Huang and Mason, 2013). Such devices enable the end users to
perform all the steps from sampling to obtaining easily readable
results in a single platform. MNPs have been used in developing
such bioassays (Rocha-Santos, 2014; Van Reenen et al., 2014).
MNPs allow integration into microfluidic devices where they can
be manipulated within the microfluidic channels by applying
an external magnetic force (Giouroudi and Keplinger, 2013).
This can lead to the design of miniaturized technologies
based on MNPs which significantly reduce sample volume and
analysis time.
After specific analyte capture using MNPs, a detection step
is crucial to provide accurate and specific detection of the
analyte-MNP complex. Several strategies have been explored
by researchers for the detection of the analyte-MNP complexes
(Gijs et al., 2009). Labeling strategies are commonly used, where
the captured analyte is labeled with a fluorescent dye (Peyman
et al., 2008, 2009; Tarn et al., 2010; Sasso et al., 2012), a
chemiluminescent molecule or an enzyme, that enable further
detection. Thorough washing or separation steps are required
when using labeled strategies so that only the captured analytes
are labeled and only the bound labels are detected. Using
fluorescent molecules as labels results in high limits of detection
(LODs) since the background fluorescence from the MNPs is
significant and thus the fluorescence from the label itself is
comparatively weak (Peyman et al., 2009). Chemiluminescent
molecules are also commonly used as labels and are considered
one of the most sensitive immunoassays where the intensity
of luminescence emitted from chemical reactions is measured
(Zhang et al., 2011; Kim and Lim, 2015). Although they
exhibit very low LODs (Wang et al., 2012), chemiluminescent
emission intensities are sensitive to environmental factors such
as temperature, solvent ionic strength, pH, and other species
present in the system. Moreover, emission intensity from the
chemiluminescent reaction varies with time. Therefore, the
emission versus time profile varies greatly from one compound to
another (Baeyens et al., 1998). When enzymes are used as labels
in enzyme-linked immunosorbent assays (ELISAs), addition of
substrates that convert the enzymes into a measurable signal is
required (Sista et al., 2008). Enzymatic labeling has the advantage
that the signal is amplified by the enzymatic conversion process.
However, several incubation and washing steps are required,
which are not desirable. Alternatively, the use of MNPs as labels
in surface binding assays has been explored where the analyte-
MNP complexes bind specifically on a surface in a sandwich
format (Morozov and Morozova, 2006; Dittmer et al., 2008).
To this purpose, specific bioreceptors with affinity toward two
different epitopes of the analyte are required to be immobilized
on the MNPs and on the surface.
Nanoporous anodic alumina (NAA) membranes have been
demonstrated as suitable substrates for developing biosensing
platforms owing to their exceptional features such as highly
ordered nanopores, tunable pore geometry, high surface-to-
volume ratio, thermal and mechanical stability, biocompatibility,
and chemical resistance (Jani et al., 2013; Santos et al., 2013;
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Rajeev et al., 2018a). Various electrochemical biosensors have
been developed using NAA as the sensing platform (Santos
et al., 2013; Rajeev et al., 2018b). NAAmembranes functionalized
with specific bioreceptors have been used to electrochemically
detect various analytes such as DNA (De La Escosura-Muñiz
and Merkoçi, 2010), proteins (De La Escosura-Muñiz and
Merkoçi, 2010), and pathogens (Cheng et al., 2012; Nguyen et al.,
2012). Detection is carried out by monitoring changes either in
impedance or current intensity upon specific analyte binding to
the immobilized bioreceptor, which partially blocks the diffusion
of a redox species through the nanopores toward the underlying
electrode surface. De la Escosura-Muñiz et al. demonstrated the
use of NAA membrane for in situ monitoring of parathyroid
hormone-like hormone (PTHLH) secretion in cultured human
cells using electrochemical detection (De La Escosura-Muñiz
et al., 2018). Recently, De la Escosura-Muñiz et al. also developed
a methodology for electrical monitoring of virulence factors
secreted by bacterial pathogens using NAA membranes (De
La Escosura-Muñiz et al., 2019). AuNP tags have been used
by Merkoçi’s group as pore blockage agents in NAA-based
electrochemical biosensors. Signal enhancement using AuNPs
in a sandwich immunoassay approach aimed to detect an IgG
lowered the LOD to 50 ng/ml compared to a LOD of 500µg/ml
achieved by an equivalent NAA immunosensor based on direct
detection (De La Escosura-Muñiz and Merkoçi, 2010, 2011).
In this work, we report a pore blockage-based electrochemical
magnetoimmunosensor where the MNPs are demonstrated as
pore blockage enhancers. Results show that simply applying a
magnetic force to pull the analyte-MNP complex toward the
sensor surface significantly pushes the LOD down, being 2,400-
folds lower than that achieved in the absence of magnetic field.
The combination of NAA pore blockage-based sensing systems
along with the unique features of MNPs in immunosensing
is highly promising to develop diagnostic platforms fulfilling
the requirements of point-of-care devices. There have been
other studies published in the past using gold or magnetic
nanoparticles (MNP) as pore blockage enhancers on NAA-
membranes. For example, in a work published by Ye et al. (2016),
NAA membranes integrated into a PDMS chamber with a Pt
electrode as working electrode were combined with the use of
MNP as pore blockage enhancers for histamine detection in
seafood. In another work published by De La Escosura-Muñiz
and Merkoçi (2011), they used a NAA membrane on a screen-
printed carbon electrode as sensor surface and AuNPs as pore
blockage enhancers for the detection of proteins in whole blood.
In this work, for the first time we demonstrated the use of
magnetic field to concentrate MNP bound analytes on the sensor
surface to enhance the pore blockage.
Flightless I is a negative regulator of wound healing which is
present at high level in chronic, non-healing wounds (Ruzehaji
et al., 2012). Flightless neutralizing antibodies (FnAb) have been
developed by Cowin group. Use of these neutralizing antibodies
show that Flii can be depleted from wound fluid and that they
have a positive therapeutic effect on chronic wounds (Cowin
et al., 2007; Kopecki et al., 2012; Ruzehaji et al., 2014). Detection
of Flii proteins in chronic wounds is of great interest in chronic
wound research since it may be an indication of the wound status
in non-healing wounds. However, wound fluid is a complex
biological sample containing a plethora of biomolecules involved
in wound healing which can cause significant matrix effects
during biosensing. MNPs can help to tackle this issue, as they are
known to isolate specific biomolecules from complex biological
samples, eliminating or at least reducing potential interferences.
We aim here to develop a pore blockage-based biosensing
platform with sensitivity enhancement via MNP-boosted pore
blockage as a proof of concept for the electrochemical detection
of Flii proteins. Isolated or recombinant whole Flii protein is
not readily available. Hence, a synthetic peptide corresponding
to the active region of Flii protein conjugated to a keyhole limpet
hemocyanin (KLH) carrier protein is used in this study as a
model analyte that facilitates a sandwich immunoassay. While
FnAbs are used as immobilized antibodies on the NAA sensor
surface, commercial polyclonal anti-KLH antibodies are used
as the bioreceptors on the MNP surface. Anti-KLH antibodies
displayed on the MNPs specifically capture the KLH-Flii peptide
conjugate from solution. MNPs with bound analyte are then
incubated onto the FnAb-modified NAA sensor surface to
perform a sandwich assay within the nanopores. Partial blockage
of the pores upon binding impedes free diffusion of a redox
species, [Fe(CN)6]4−, toward the underlying gold transducer
surface, measured as a decrease in its oxidation current intensity.
We compared the sensing performance in the presence and
absence of magnetic field to study the effect of the magnetic
attraction on facilitating the access of the KLH-Flii peptide
conjugate-MNP immunocomplex into the pores and thus on the
achieved sensitivity.
MATERIALS AND METHODS
Reagents
NAA membranes of 200 nm pore diameter (Whatman Anodisc
Circles 13mm, 200 nm) were purchased from Interpath
services (Australia). Carboxyl-terminated MNPs (100 nm
diameter, 25 mg/ml, fluidMAG-ARA) were purchased from
Chemicell (Germany). Potassium ferrocyanide (K4[Fe(CN)6]),
potassium ferricyanide (K3[Fe(CN)6]), N-hydroxysuccinimide
(NHS), N-(3-dimethylaminopropyl) N′-ethylcarbodiimide
hydrochloride (EDC), ethanolamine, phosphate buffered saline
(PBS) tablets, 3-(triethoxysilyl) propyl isocyanate (ICN) silane,
3,3′,5,5′-tetramethylbenzidine (TMB) substrate, and 2-(N-
morpholino)-ethanesulfonic acid (MES) were purchased from
Sigma-Aldrich (Australia).
Polyclonal antibodies against KLH produced in rabbit
and anti-human IgG antibodies (used as control) were
purchased from Sapphire Bioscience (NBP1-30443, Australia).
Monoclonal antibodies raised in mouse against the N-terminus
of the LRR domain of the human Flii protein (FnAb) were
developed and supplied by Cowin group (Jackson et al., 2012).
Custom made KLH-Flii peptide conjugate was purchased from
Mimotopes (Australia).
Preparation and Characterization of
Antibody-Modified MNPs (MNP-Ab2)
Carboxyl-terminated MNPs were modified with anti-KLH
antibodies (Ab2) via carbodiimide chemistry. One microliter of
MNPs, which is equivalent to 4.5·1010 particles, was added to 100
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µl of MES buffer, pH 5. MNPs were washed by 5 min-incubation
in MES buffer with good mixing in an orbital shaker, followed
by 4 min-capture on a magnet to allow supernatant removal.
This washing step was performed 3 times. Carboxyl groups on
the washed MNPs were activated to form NHS ester groups by
reacting with a 1:1 mixture of 100 µl of 0.4M of EDC and 0.1M
of NHS in cold MES buffer. This reaction was conducted under
goodmixing in an orbital shaker for 30min at room temperature.
Then, the activated MNPs were captured on a magnet for
5min and the supernatant was removed. Activated MNPs were
incubated in 100 µl of 50µg/ml of Ab2 in 0.01M PBS, pH 7.6,
for 1 h at room temperature. Antibody-modified MNPs were
washed 4 times in PBS containing 0.01% Tween 20, following
the washing protocol previously described, to remove any non-
specifically bound antibodies. Ab2-modified MNPs (MNP-Ab2)
were incubated in 100 µl of 0.1M ethanolamine in PBS for 1 h
to block any remaining active ester groups on the MNPs surface.
Modified MNPs were stored at 4◦C until further use.
Fourier transform infrared (FTIR) spectroscopy was
conducted after each surface modification step. FTIR spectra
were obtained using a Vertex 70 Hyperion microscope Bruker
in reflectance mode (Bruker Optics, Germany) over the range
of 650–1,000 cm−1 at a resolution of 4 cm−1 and averaging
64 scans. Background spectra were taken on a gold-coated
glass slide. Samples for FTIR characterization were prepared by
placing a small drop of unmodified MNP solution, NHS ester-
activated MNP solution, and Ab-modified MNP solution on the
surface of the gold slide and drying them in a desiccator under
vacuum to generate a thin layer of MNPs. Sample spectra were
recorded and data analyzed using the OPUS 7.2 spectroscopy
software (Bruker).
Preparation and Characterization of the
NAA Immunosensing Surface
Isocyanate groups were introduced on the surface of the NAA
membranes with 200 nm pores via silanization to facilitate
further covalent immobilization of the bioreceptor FnAb. Briefly,
NAA membranes were boiled in 30% H2O2 for 1 h to obtain
fresh hydroxyl groups and remove any organic contaminants.
Hydroxylated membranes were dried under a mild nitrogen flow
and baked in an oven at 60◦C for 2 h to remove any remaining
water content. This is a key step since the silanes are highly
reactive to water. Then, the membranes with active hydroxyl
groups were immersed in a 5% solution of ICN silane in dry
toluene in a sealed reaction vessel under nitrogen atmosphere.
Silanization was carried out for 2 h under constant shaking
at room temperature and inert atmosphere, which resulted in
isocyanate groups (-N=C=O) displayed on the NAA surface.
After silanization, the functionalized membranes were washed
with fresh dry toluene and dried under a nitrogen stream. Finally,
they were incubated with a 50µg/ml FnAb (Ab1) solution
in 0.1M PBS (pH 7.4) for 2 h under constant shaking. After
incubation, membranes were washed thoroughly with copious
amount of PBS, and stored in PBS at 4◦C until they were used
for sensing experiments.
FTIR spectroscopy was used to characterize the membranes
surface after each step of modification. FTIR spectra were
obtained using the method described in section Preparation and
Characterization of Antibody-Modified MNPs (MNP-Ab2).
Scanning electron microscopy (SEM) was used to characterize
the surface morphology of the NAA membranes.
Analyte (KLH-Flii-Conjugate) Isolation
Using MNP-Ab2
MNPs-Ab2 were used to capture the KLH-Flii peptide conjugate
from solution as shown in Scheme 1. MNPs-Ab2 were incubated
in 100 µl of Flii peptide conjugate at various concentrations (2.5,
5, 10, 20, and 40µg/ml) in PBS for 1 h at room temperature
with good mixing. Afterwards, MNPs-Ab2 with captured analyte
(MNP-Ab2-Flii) were washed 3 times in PBS solution containing
0.01% Tween 20 using the protocol previously described and the
washed MNP-Ab2-Flii complex was re-suspended in fresh PBS
and used for sensing experiments.
ELISA to Detect MNP-Ab2-Flii Complex
Detection of MNP-Ab2-Flii complex was initially carried out by
colorimetric ELISA to confirm the feasibility to use the involved
immunospecies in a sandwich assay and to compare the sensing
performance of this colorimetric assay with that achieved by
the novel NAA-based electrochemical immunosensor which uses
MNPs as pore blockage enhancers. Briefly, isolated MNP-Ab2-
Flii complex was incubated first in 100 µl of 50µg/ml Ab1
in PBS for 1 h followed by incubation in a 1:5,000 dilution of
HRP-labeled anti-mouse IgG in PBS. Every incubation step was
followed by 3 washing steps in PBS containing 0.01% Tween
20 followed by one washing step in PBS. One hundred µl of
TMB were added as HRP substrate. The catalytic conversion of
the chromogenic substrate TMB into a colored product by the
enzyme used as label was followed by measuring the absorbance
at 650 nm, allowing target quantification.
Electrochemical Detection of MNP-Ab2-Flii
Complex on a NAA-Based Immunosensor
Electrochemical sensing was conducted using an electrochemical
analyser (CH Instruments, model 600 D series, USA) and a three-
electrode system in a Teflon cell. Ab1-modified NAA membrane
mounted on a gold-coated glass slide (Au/NAA-Ab1) acted as
the working electrode, a silver/silver chloride electrode (CH
Instruments, USA) was the reference electrode and a platinum
wire was the counter electrode. Electrochemical measurements
were done using a 2mM K4[Fe(CN)6] and 2mM K3[Fe(CN)6]
solution in 0.1MPBS. Differential Pulse Voltammetry (DPV)was
used as detection technique in which a series of regular voltage
pulses were applied ranging from−0.3 to 0.8V and the oxidation
current of the redox species was measured at 0.18 V.
One hundred µl of MNP-Ab2-Flii complex in PBS, obtained
upon incubation of MNP-Ab2 in solutions of different
concentrations of Flii peptide conjugate (2.5, 5, 10, 20, and
40µg/ml), were incubated on the immunosensor surface for 1 h
at room temperature. DPVmeasurements were performed before
and after incubating the MNP-Ab2-Flii complex solutions. Each
experiment was performed in triplicate. Control experiments
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SCHEME 1 | Isolation of KLH-Flii peptide conjugate using MNPs.
were done using an anti-human IgG-modified NAA-based
sensor to evaluate whether the MNP-Ab2-Flii complex was
non-specifically adsorbed on the membrane.
Sensitivity Enhancement Using External
Magnetic Field
A strong external magnetic field using a large rare earth
magnet made from neodymium, iron, and boron-NdFeB (Jaycar
Electronics, Australia) was applied at the backside of the
immunosensing surface to study its effect on the sensing
performance by providing an additional force to attract theMNP-
Ab2-Flii complex into the pores and thus facilitates its binding to
the Ab1 immobilized on the NAA surface. We hypothesize that
this novel approach can enhanceMNP-Ab2-Flii complex binding
by overcoming diffusion limitations that limit analytes entering
the pores, and thus amplify the sensing signal and eventually
enhance the sensitivity. In the absence of magnetic field, the
MNP-Ab2-Flii complex enters the pores only by diffusion and
gravitational forces. The externally applied magnetic field acts
as an extra force to attract the MNP-Ab2-Flii complex which
facilitates its effective path toward the sensor surface and thus
its exposure and final binding to the immobilized Ab1, thereby
acting as pore blockage enhancers. Stringent washing while
placing the magnet on top of the sensor was required after
the MNP-Ab2-Flii complex incubation under magnetic field to
remove anyMNPs that may be non-specifically bound or trapped
within the pores.
RESULTS AND DISCUSSION
Immobilization of Anti-KLH on MNPs and
FnAb on NAA Membranes
MNPs were used to harvest KLH-Flii peptide conjugate from
solution. To that purpose, first anti-KLH antibody (Ab2) was
covalently bound to carboxyl-terminated MNPs. Carboxyl-
terminated MNPs have a particle size of 100 nm, confirmed using
TEM (Figure 1A). Carbodiimide chemistry is the most versatile
method to activate carboxylic groups for their binding to primary
amines, EDC being the most popular carbodiimide used for
this purpose. NHS was used in the EDC coupling protocols to
improve the efficiency of the reaction by creating an amine-
reactive intermediate. EDC couples NHS to carboxyl groups and
forms an NHS ester which is more stable than the O-acylisourea
intermediate formed in the absence of NHS. The NHS ester
intermediate reacts with the amine groups of the antibody to
form stable amide bonds. Figure 1B presents the FTIR spectra
at different modification steps of MNPs. The spectrum of the
carboxyl-terminated MNPs before activation (black) shows a
strong band at 1,624 cm−1 and a broad band at 3,400 cm−1
which are characteristic of C=O stretching and O-H stretching,
respectively. This confirms the presence of carboxylic groups
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FIGURE 1 | TEM characterization of MNPs (A), and FTIR spectra of MNPs at
different modification steps: unmodified MNPs (black) after EDC/NHS
activation (red) and after Ab2 immobilization (blue) (B).
on the MNPs surface. EDC/NHS activation results in an NHS
ester intermediate, reflected in the corresponding FTIR spectrum
(red) as a characteristic triplet peak at 1,724, 1,751, and 1,820
cm−1 (Böcking et al., 2008; Sam et al., 2009). The bands at 1,724
and 1,751 cm−1 correspond to the C=O anti-symmetric and
C=O symmetric stretching vibrationalmodes of the succinimidyl
ring, respectively. The band at 1,820 cm−1 corresponds to the
C=O symmetric stretching vibrational mode and the C=O
stretching vibrational mode of the succinimidyl ester. After
antibody binding, the FTIR spectrum (blue) shows two bands at
1,556 and 1,637 cm−1 that confirm the formation of amide bonds
between the activated MNPs and the antibody. These bands
correspond to the amine I and amine II vibrations, respectively.
The surface for immunosensing was prepared as detailed in
the experimental section Preparation and Characterization of the
NAA Immunosensing Surface. Silanization chemistry was used
to immobilize FnAb within the porous layer. The NAA porous
surface is characterized by a high density of native hydroxyl
groups. These groups were activated by boiling in H2O2 at 70◦C
for 1 h. This step also removes any organic contaminants from
the surface and forms fresh hydroxyl groups. The hydroxylated
surface was functionalized by means of silanization chemistry
using ICN silane. This produced a dense monolayer of ICN
silane with highly reactive isocyanate groups (N=C=O) on
the NAA surface. This group readily reacted with the amine
groups of FnAb. FTIR spectroscopy was used in reflectance
mode to confirm the surface modification steps of the NAA
membranes. Figure 2A presents the FTIR spectra at different
NAA surface modification steps. The broad peak at 3,340 cm−1
in the black spectrum in Figure 2A corresponds to hydroxyl
groups on NAA surface after hydroxylation. The spectrum of
the NAA surface after reacting the hydroxylated membrane with
ICN silane (red spectrum in Figure 2A) showed a characteristic
band at 2,250 cm−1 representing N=C=O stretching vibration
mode, confirming the successful silanization and presence of
isocyanate groups on the surface. Bands at 2,925 and 2,854 cm−1
were assigned to the stretching vibration modes of the aliphatic
CH2 groups in the silane (Dronov et al., 2011). In this same
spectrum, bands at 1,550 and 1,650 cm−1 were present which
are characteristics of C=O stretching and N-H bending vibration
modes. The presence of these bands is attributed to the fast
hydrolysis undergone by some of the isocyanate groups upon
reaction with residual water in the solvent or water vapor in
the atmosphere. The blue spectrum in Figure 2A was obtained
after covalent immobilization of FnAb on the silanized NAA
surface. It confirms successful immobilization of antibodies via
the disappearance of the isocyanate band at 2,250 cm−1 and
the presence of intense bands at 1,550 cm−1 (N-H bending
vibration mode) and 1,650 cm−1 (C=O stretching vibration
mode) from the peptide bonds formed between the antibodies
and the isocyanate groups (Dronov et al., 2011).
Scanning SEM was used to characterize the surface
morphology of the NAA membrane (Figure 2B). The top
view of the membranes revealed that they had an average pore
diameter of 207± 11 nm.
Detection of MNP-Ab2-Flii Complex on
NAA Membranes
Before conducting electrochemical sensing experiments on
the NAA immunosensing surface, initially we performed a
colorimetric ELISA as described in the experimental section
ELISA to Detect MNP-Ab2-Flii Complex, to confirm that
the sandwich format works well and to compare its sensing
performance with that of the NAA-based immunosensor.
Figure 3A shows the scheme for the sandwich colorimetric
ELISA. Absorbance was measured at 650 nm and plotted against
the logarithm of KLH-Flii peptide conjugate concentrations (2.5,
5, 10, 20, and 40µg/ml). The colorimetric ELISA detection based
on a sandwich assay provided a LOD of 2.9µg/ml, calculated
using the equation 3Sa/b, where Sa is the standard deviation of
the y-axis and b is the slope of the linear range of the calibration
curve (Figure 3B). The sensitivity of this system was found to be
0.52 ml/µg.
The sensitivity achieved by the described ELISA is expected
to be improved by the developed NAA-based electrochemical
immunosensor combining the properties of MNPs, NAA
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FIGURE 2 | FTIR spectra of NAA immunosensing surface at different
modification steps: after hydroxylation (black), silanization (red) and Ab1
immobilization (blue) (A), and SEM top-view image of NAA (B).
membrane and pore blockage-based electrochemical
transduction method as explained previously.
As shown in Scheme 2, pore blockage was used as sensing
principle to detect MNP-Ab2-Flii complex on a NAA-based
immunosensor. Pore size is key to allow access of the
immunocomplexes and maximize blockage, and thus sensitivity,
upon binding to the immobilized antibodies. Formation of
sandwich immunocomplexes within the pores partially blocks
the diffusion of the redox species present in solution toward
the gold transducer surface. This results in a reduction in the
voltammetric oxidation signal of [Fe(CN)6]4− to [Fe(CN)6]3−
used to quantify the concentration of KLH-Flii peptide conjugate.
The pore blockage sensing principle using NAA membranes
has been demonstrated as an efficient label-free biomolecule
detection approach (De La Escosura-Muñiz and Merkoçi, 2010;
De La Escosura-Muñiz et al., 2013; Espinoza-Castañeda et al.,
2015). We show here the advantages of using MNPs in
FIGURE 3 | Scheme (A) and dose response curve (B) for the colorimetric
ELISA detection of Flii peptide conjugate, previously isolated using MNPs.
combination with a pore blockage-based immunosensor, not
only to enhance the sensitivity, but also to capture the analyte
from complex samples and thus avoid matrix effects caused
by interfering compounds. Additionally, manipulation of MNPs
by an external magnetic field can be utilized to facilitate the
access of MNPs containing the immunocomplex into the pores to
increase their availability for immunoreaction with the antibodies
immobilized on the pores surface. This amplification strategy is
expected to significantly improve the sensing sensitivity. Hence in
this research, we demonstrate the use of MNPs as pore blockage
enhancers and the possibility to further increase the sensitivity by
applying an external magnetic field.
Figure 4A shows the DPV curves obtained after incubating
the MNP-Ab2-Flii complex solutions, obtained upon incubation
of MNP-Ab2 in various solutions with KLH-Flii peptide
concentrations ranging from 2.5 to 40µg/ml, on the NAA-
based immunosensor in the absence of magnetic field. As
expected, the oxidation current decreased with binding of the
MNP-Flii complex obtained upon incubation with increasing
concentrations of KLH-Flii peptide conjugate. To prove the
specific binding between MNP-Flii peptide conjugate complex
and the FnAb immobilized on the pores surface, a control
experiment was performed using a NAA-based sensor modified
with an anti-human IgG (Figure 4B).
To evaluate the sensing performance, current intensity
changes were normalized using the following equation:
Ip =
(I0-Ip)
I0
× 100
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SCHEME 2 | Sensing principle of pore blockage-based electrochemical detection using MNPs as enhancers.
where ∆Ip was the % current intensity change and I0 and
Ip were the current intensity values measured prior and after
incubation with MNP-Ab2-Flii peptide conjugate. Calibration
curves were obtained by plotting ∆Ip as a function of log
[Flii peptide conjugate] (maximum standard deviation of 4.4%;
Figure 4C). The response from the control sensor (red triangles
in Figure 4C) was negligible compared to the response from
the Flii NAA immunosensor (black squares in Figure 4C),
proving that the sensing response was due to specific binding
between the MNP-Flii peptide conjugate complex and the Ab1
immobilized on the pores surface. The LOD was found to be
1.2µg/ml, being only somewhat better than that obtained by
ELISA (Figure 3B) which is 2.9µg/ml. However, the sensitivity
of the proposed sensing system was 76 times higher (40
ml/µg) than that of the ELISA which had a sensitivity
of 0.52 ml/µg. The proposed NAA-based electrochemical
immunosensor significantly improved the performance of the
ELISA even in the absence of magnetic field. Reproducibility
of the developed immunosensors was calculated as the relative
standard deviation of the sensitivity of three individual sensors,
being 3.8%. Encouraged by the outstanding improvement in
sensitivity of the NAA-based immunosensor using MNPs as
pore blockage enhancers, we then combined the same detection
strategy with the application of an external magnetic field.
We expect this approach to further improve the sensitivity by
facilitating access of the immunocomplex into the pores, as
described in the next section.
Sensitivity Enhancement Using External
Magnetic Field
Our initial hypothesis was that the sensing performance of the
developed pore blockage-based electrochemical immunosensor
could be greatly enhanced in terms of sensitivity by applying
an external magnetic field at the backside of the electrode. In
the presence of the magnetic field, MNPs with bound analyte
molecules are actuated in the direction of the magnetic field.
This is an additional force for the MNPs to go through the
pores apart from diffusion and gravitational pull when sensing
is performed in the absence of magnetic field. This facilitates
the binding of the MNP-Ab2-Flii complex to the bioreceptors
(FnAb) immobilized on the pores surface and thus enhances
the pore blockage effect. The immunosensor was placed on top
of a large rare earth magnet made from neodymium, iron and
boron-NdFeB during MNP-Ab2-Flii complex incubation. After
that, thorough washing was performed with the magnet on top of
the pores to magnetically drive any unbound MNPs stuck inside
the pores outside the membrane by placing the magnet on top of
the sensor.
Sensing experiments were performed by incubating
MNP-Ab2-Flii complex solutions obtained upon MNP-Ab2
incubation in various KLH-Flii peptide conjugate solutions
with concentrations ranging from 2.5 ng/mL to 2.5µg/mL.
DPV curves before and after incubation of MNP-Ab2-Flii
complex on a NAA-based immunosensor and a control sensor,
in the presence of an external magnetic force, are shown in
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FIGURE 4 | DPV curves obtained with the NAA-based electrochemical
immunosensor (A), and the control sensor (B) in the absence of magnetic
field; dose response curves for the detection of KLH-Flii peptide conjugate
plotted using the NAA-based electrochemical immunosensor and control
sensor in the absence of magnetic field (C). Error bars are calculated as
standard deviation from the average of three individual experiments.
FIGURE 5 | DPV curves obtained with the NAA-based electrochemical
immunosensor (A), and the control sensor (B) when an external magnetic field
is applied during the analyte incubation step; dose response curves for the
detection of KLH-Flii peptide conjugate plotted using the NAA-based
electrochemical immunosensor and control sensor when an external magnetic
field is applied during the analyte incubation step (C). Error bars are calculated
as standard deviation from the average of three individual experiments.
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Figures 5A,B, respectively. Calibration curves were plotted
as explained previously to evaluate the sensing performance
(maximum standard deviation of 2.8%; Figure 5C). The
response from the control sensor (red triangles in Figure 5C)
was negligible compared to that from the specific NAA
immunosensor (black squares in Figure 5C). A LOD of
0.5 ng/mL was obtained, providing 5,800 and 2,400-fold
enhancement, respectively, compared to the results obtained
using ELISA and the same NAA-based immunosensor in the
absence of magnetic field. A sensitivity of 27·103ml/ µg was
achieved which is 673 times higher than that obtained by the
immunosensor in the absence of magnetic field. Application
of an external magnetic field to manipulate the particles seems
to enhance the pore blockage effect as demonstrated by the
ability to detect KLH-Flii peptide conjugate at concentrations
1,000-folds’ lower than in the absence of magnetic field. The
immunosensor performance in terms of sensitivity and LOD
was greatly enhanced using the developed sensing strategy
by magnetically manipulating the access of MNPs into the
pores, while still showing an excellent reproducibility among
sensors (2.8%).
These results confirm that by combining the use of MNPs as
pore blockage agents and the application of an external magnetic
field during analyte incubation, the NAA-based electrochemical
immunosensor performance can be greatly improved when pore
blockage is used as sensing mechanism. This sensing system has
the potential to be extended to detect low concentrations of small
molecules. Due to the ability of MNPs to isolate a target analyte
from a complex biological sample, it may well be suitable to
detecting biomarkers in samples with complex matrices.
CONCLUSIONS
We report here the development of a pore blockage-based
biosensing platform with sensitivity enhancement via MNPs
as a proof of concept for the electrochemical detection of
Flii proteins. We have successfully demonstrated the proof-of-
principle of the use of MNPs as signal enhancers in combination
with FnAb-modified NAA platforms based on pore blockage
as sensing mechanism. A synthetic peptide corresponding
to the active region of the wound biomarker Flii protein
conjugated to a KLH carrier protein was used as a model
analyte. MNPs were modified with an anti-KLH antibody to
specifically capture the Flii-KLH conjugate. Then, the MNP-
Ab2-Flii complex was subsequently captured by the FnAb
antibodies within the NAA porous structure causing partial
pore blockage. Pore blockage was used as sensing principle,
being measured as a reduction in the voltammetric oxidation
current of a redox species added in solution. Enhancement in
pore blockage was achieved by applying an external magnetic
field which pulled the MNP-Ab2-Flii complex more efficiently
toward the sensor. This resulted in a significant enhancement
in the analytical signal achieving a LOD of 0.5 ng/ml, while
the LOD achieved in the absence of magnetic field was
1.2µg/ml. Our results confirm that this novel sensing strategy
can be used for developing biosensing platforms with enhanced
sensing performance.
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